Company will expand the existing production site in Wuxi to significantly increase biopharma single-use assemblies and custom design capabilities
The planned Phase 1 study is a double-blind, randomized, placebo-controlled dose-escalation study in healthy adult subjects and AD patients
In addition, common light chain antibodies generated by RenLite mice can greatly improve the efficiency of downstream assembly of complex drug molecules such as bispecific antibodies and bispecific antibody-drug conjugates (bsADCs)
Aflibercept is the second biosimilar product that has entered the clinical trial phase after biosimilar Adalimumab
New high-throughput, no-wash assays contribute to the development, manufacture and quality control of safer, more effective biotherapeutics
Cantex also plans to initiate Phase 2 clinical trials exploring the therapeutic effect of azeliragon in pancreatic and breast cancers.
Bangladesh, Indonesia, Pakistan, Serbia and Vietnam to receive mRNA technology from the technology transfer hub
Newly formed Life Science Services business unit to offer fully integrated CDMO and Contract Testing Services
Company to manufacture drug substance for clinical supply of HaemaLogiX’s lead multiple myeloma drug candidate, KappaMab, at its new state-of-the-art facility in Guangzhou, China
Their strong recommendation is based on moderate certainty evidence that it improves survival and reduces the need for ventilation
Subscribe To Our Newsletter & Stay Updated
